Theravance Biopharma TBPH
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 14.60 | 278.67 | 56.43 | 0.07 | -6,454 | 4 |
| 2025Q2 | 11.03 | -3.69 | 1.08 | -2,725 | 55 | |
| 2025Q1 | 8.93 | 106.96 | -0.27 | -14,434 | -14 | |
| 2024Q4 | 9.41 | 110.90 | -0.31 | -9,200 | -16 | |
| 2024Q3 | 8.06 | 115.02 | -0.26 | -10,837 | -13 | |
| 2024Q2 | 8.48 | 107.74 | -0.34 | -15,705 | -17 | |
| 2024Q1 | 8.97 | 114.67 | -0.24 | -11,207 | -12 | |
| 2023Q4 | 11.24 | 142.04 | -0.19 | -6,240 | -9 | |
| 2023Q3 | 8.63 | 125.61 | 0.52 | -0.18 | -8,760 | -9 |
| 2023Q2 | 10.35 | 118.39 | 0.68 | -0.28 | -16,123 | -16 |
| 2023Q1 | 10.85 | 113.58 | 0.84 | -0.35 | -24,912 | -22 |
| 2022Q4 | 11.22 | 127.15 | 0.89 | 0.19 | -17,431 | -10 |
| 2022Q3 | 10.14 | 98.09 | 12.11 | -14,202 | 917 | |
| 2022Q2 | 9.06 | -102.32 | -0.11 | -28,158 | -8 | |
| 2022Q1 | 9.56 | 279.67 | -0.34 | -38,502 | -26 | |
| 2021Q4 | 11.05 | -116.63 | -0.41 | -56,167 | -32 | |
| 2021Q3 | 7.40 | 227.44 | -0.43 | -53,615 | -35 | |
| 2021Q2 | 14.52 | 156.32 | -0.79 | -64,110 | -52 | |
| 2021Q1 | 20.41 | 124.14 | -1.24 | -83,892 | -80 | |
| 2020Q4 | 17.77 | 137.69 | -0.91 | -76,490 | -58 |